CDGEMM: Studio sulla malattia celiaca
Benvenuto! CDGEMM sta per Celiac Disease Genomic Environmental Microbiome and Metabolomic Study (Studio Genomico Ambientale Microbiomico e Metabolomico nella Malattia Celiaca) e recluta bambini che hanno un parente di primo grado con celiachia.
- About CDGEMM
- How CDGEMM Is Making History
- About Celiac Disease
- CDGEMM Frequently Asked Questions
- How to get involved
- Participating centers
- Gut Microbiota in Infants: First Results from the CDGEMM Study
- Multi-omics analysis reveals the influence of genetic and environmental risk factors on developing gut microbiota in infants at risk of celiac disease
The CDGEMM Study is currently recruiting infants in the womb or aged up to 6 months who have a first-degree relative (parent or sibling) with celiac disease.
For study updates and more information from the Center for Celiac Research, visit our website, Facebook and Twitter pages! You can also find details about the CDGEMM study on clinicaltrials.gov and on the Partners Healthcare clinical trials registration page.
Interested in sharing information about CDGEMM in your healthcare setting?
This flyer can be posted or distributed freely to any interested care providers or potential participants. Thank you for helping to spread the word about CDGEMM!
Meet the Team
- Alessio Fasano, MD
- Maureen Leonard, MD
- Mark A. Salvatore, MD
- Martha Pacetti, RN, MSN, CPNP
- Pam Cureton, RD, LDN
- Gloria Serena, PhD
- Tori Kenyon, Research Coordinator
As of November 2018, the CDGEMM Study has enrolled 177 infants in the United States and 162 in Italy, and 28 infants in Spain. Check out our recent newsletters below for additional updates on study progress.
Got Comments? CDGEMM participants and care providers are encouraged to submit comments or concerns about the study through this anonymous portal. We love to hear your feedback!